Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for PRCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -2.953M
March 31, 2026 -2.914M
December 31, 2025 -1.85M
September 30, 2025 -2.868M
June 30, 2025 -2.802M
March 31, 2025 -1.836M
December 31, 2024 -1.174M
September 30, 2024 -0.246M
June 30, 2024 -1.043M
March 31, 2024 -1.946M
December 31, 2023 -8.715M
September 30, 2023 -5.78M
Date Value
June 30, 2023 -5.372M
March 31, 2023 -5.339M
December 31, 2022 -0.866M
September 30, 2022 -1.514M
June 30, 2022 -0.218M
March 31, 2022 -0.055M
December 31, 2021 -0.332M
September 30, 2021
June 30, 2021
March 31, 2021 0.00
December 31, 2020 -0.009M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Insulet Corp. -37.40M
Globus Medical, Inc. -129.05M
Abbott Laboratories -673.00M
Alphatec Holdings, Inc. -22.72M
Artivion, Inc. -129.41M